BioCentury
ARTICLE | Clinical News

Faslodex fulvestrant: Phase III data

July 11, 2016 7:00 AM UTC

The double-blind, double-dummy, international Phase III FALCON trial in about 524 postmenopausal women with hormone receptor-positive locally advanced or metastatic breast cancer who have not previous...